Stay Informed on Corporate Sustainability

Author: Jed Nykolle Harme

Pharma and life sciences remain at the forefront of global transformation, with resilience, innovation and agility emerging as the defining features of the sector’s growth. This edition highlights how excellence and adaptability are shaping both operations and outcomes, offering lessons well beyond healthcare. The Pharma Industry Awards has unveiled its shortlist, marking a pivotal moment in Ireland’s pharmaceutical calendar and underlining its role as a leading platform for recognising achievement. Operational strategy is equally significant, as SGS expands agile insourcing solutions, demonstrating how efficiency, scale and flexibility can safeguard competitiveness in a shifting market and meet growing global demand. Investor sentiment remains another crucial indicator. Atai Life Sciences hitting a 52-week high showcases confidence in innovation-led growth, underscoring the sector’s ability to capture capital, drive momentum and convert research investment into tangible results. These stories illustrate a sector not simply responding to challenges but actively reshaping them into opportunities. For leaders, the lesson is clear: excellence in standards, strategic agility, and innovation-driven sustainability are the cornerstones of long-term success and global impact.

Author: Chemanager

Merck has inaugurated its first climate-neutral life sciences production facility at Blarney, Cork, as part of a €440 million investment program in Ireland. The plant will produce critical filtration technologies to support vaccines, monoclonal antibodies, and advanced therapies while reducing cross-border dependencies.

Author: EURACTIV

Trump announces 100% tariffs on branded pharmaceuticals, sparking uncertainty for Ireland’s pharma sector. While the EU-US Joint Statement caps tariffs at 15%, Irish exporters and policymakers are assessing the potential impact on trade, investment, and supply chains amid ongoing legal and regulatory developments.

Author: Investing

Atai Life Sciences hits a 52-week high of $5.35, marking a 336% increase over the past year. Despite a Phase 2b trial setback, analyst optimism remains strong, reflecting growing investor confidence in Atai’s innovative mental health and psychedelic therapy pipeline.

Author: PRNnewswire

Rhode Island launches Ocean State Labs, its first life science incubator, to accelerate early-stage companies in therapeutics, tissue regeneration, and surgical innovation. Backed by a $45 million investment, the hub combines lab infrastructure, venture support, and academic partnerships to strengthen the state’s life sciences ecosystem.

Author: ILOVELIMERICK

The University of Limerick and Edwards Lifesciences have signed a Memorandum of Understanding to accelerate medical device innovation and talent development. The strategic partnership will support research, education, and process automation initiatives, strengthening Ireland’s biopharmaceutical and medtech ecosystem.

Author: Jed Nykolle Harme

The life sciences industry is entering a period defined not by incremental steps but by bold decisions that will shape the resilience of global healthcare.

Author: The Reuters

Global drugmakers are scrambling to shore up their U.S. manufacturing capacity and domestic inventory as the Trump administration weighs hefty tariffs on pharmaceutical imports into the country.

Author: BusinessWire

Universal Robots (UR), the world’s leading collaborative robot (cobot) company and a part of Teradyne Robotics, has today announced that long-time partner Technicon, one of the premier automation companies in the Nordics, has now officially evolved into a UR global Certified Solution Provider (CSP) for the pharmaceutical industry.

Author: The Reuters

The World Health Organization on Sunday called for the "protection of public health excellence" at the U.S. Centers for Disease Control and Prevention.